Related Experiment Video
Updated: Aug 13, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
[Sanitary risk: medicinal products and medical devices]
1Afssaps, 93285 Saint-Denis Cedex. Jean.marimbert@afssaps.sante.fr
Abstract:
Health products at large and medicinal products in particular, relieve treat and restore through a pharmacological action on human body which might bear a part of risk. Therefore, medicinal products' effects are not considered once when the product comes to the market but permanently through its life. The benefit/risk ratio evolves from day to day according to the development of scientific knowledge and the feedback we have from the use of products in their real conditions of use. The ratio is assessed differently depending on the severity degree of the disease to be treated. The cursor, and then the risk level which can be acceptable and accepted, changes over time for the same kind of diseases along with therapeutic progress. The renewal and strengthening of post-marketing authorization surveillance is based on the early adoption of risk management programs for products with high security expectations.
Related Concept Videos
Cleaning, Sterilization, and Disinfection
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
Good Manufacturing Practices
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Regulation
Methods for Controlling Microbial Growth
Pharmaceutical Poisoning: Potential Scenarios
